Specialty Pharmacy

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Top articles of the week from Specialty Pharmacy Times.

Epoetin alfa biosimilar has indications in cancer, HIV, and chronic kidney disease, among other conditions.

This is the first recommendation for a proposed erythropoiesis-stimulating agent biosimilar.

Scientists project combining prevention programs could avert up to 40,000 HIV infections over 20 years among injection drug users.

Upcoming trial of Opdivo harnesses the immune system to target mesothelioma.

Collaboration is part of a citywide plan to ensure patients with HIV receive care and to reduce the number of new HIV transmissions.

As the prevalence of diabetes continues to rise, the development of safer and more efficient therapeutics is increasing in importance.

Mark A. Vineis, vice president of specialty pharmacy at Cardinal Health, discusses how communication can be improved among manufacturers, pharmacy benefit managers, and specialty pharmacies.

Prostate cancer care costs in the United states is more than $10 billion per year.

New medical information website provides pharmacists and other providers with both in-label and potential off-label medication information.

Latest efforts help scientists identify the efficacy of immune treatments in patients with cancer.

Reducing overall body fat associated with lower levels of breast cancer markers.

New blood test more precisely distinguishes cancer from benign conditions, and identifies patients at high-risk of disease.

Top news of the day from across the health care landscape.

Cheryl Allen, vice president of Industry Relations at Diplomat, discusses the impact of direct and indirect remuneration fees on specialty pharmacy.

HIV infection may affect cognition in young patients.

Indication for the treatment of adults and pediatric patients with solid tumors containing MSI-H or dMMR.

No evidence found that erectile dysfunction drugs cause melanoma.

Study provides picture of host cell pathway mobilization to HCV.

Top news of the day from across the health care landscape.

Sarilumab plus DMARDs demonstrated statistically significant improvements in patients with moderate to severe RA.

Continuing ART post-delivery shows benefits in women with early stage HIV,

Traps help entomologists track mosquitoes that are carrying Zika or other harmful diseases.

Satisfaction surveys improve understanding of the patient journey and define specialty pharmacy excellence.

Sheila Arquette, RPh, director of Pharmacy Services at Independent Health, discusses how specialty stakeholders can improve clinical and financial alignment.

Non-EU and EEA countries trail behind in reaching viral suppression target by 2020.

Top news of the day from across the health care landscape.